医疗器械ETF领涨丨ETF基金日报
2 1 Shi Ji Jing Ji Bao Dao·2026-01-06 02:59

Market Overview - The Shanghai Composite Index rose by 1.38% to close at 4023.42 points, with a daily high of 4025.26 points [1] - The Shenzhen Component Index increased by 2.24% to close at 13828.63 points, reaching a high of 13828.97 points [1] - The ChiNext Index saw a rise of 2.85%, closing at 3294.55 points, with a peak of 3295.29 points [1] ETF Market Performance - The median return of stock ETFs was 2.12%, with the highest return from the Southern CSI Star Market 50 ETF at 4.85% [2] - The highest performing industry index ETF was the China Securities All Index Medical Devices ETF, yielding 6.95% [2] - The highest return among thematic index ETFs was from the Ping An CSI Hong Kong-Shanghai Online Consumption Theme ETF at 6.94% [2] ETF Gains and Losses - The top three ETFs by gain were: - China Securities All Index Medical Devices ETF (6.95%) - Ping An CSI Hong Kong-Shanghai Online Consumption Theme ETF (6.94%) - Yongying CSI All Index Medical Devices ETF (6.37%) [5] - The top three ETFs by loss were: - China Securities Tourism Theme ETF (-1.35%) - Fortune CSI Tourism Theme ETF (-1.11%) - Penghua CSI 800 Free Cash Flow ETF (-0.78%) [6] ETF Fund Flows - The top three ETFs by fund inflow were: - Southern CSI 500 ETF (28.42 billion) - Huatai-PB CSI 300 ETF (11.02 billion) - Southern CSI Shenwan Nonferrous Metals ETF (9.15 billion) [8] - The top three ETFs by fund outflow were: - Southern CSI A500 ETF (12.88 billion) - Huaan ChiNext 50 ETF (9.97 billion) - Huatai-PB CSI A500 ETF (8.82 billion) [9] ETF Margin Trading Overview - The highest margin buy amounts were for: - Huatai-PB CSI 300 ETF (0.776 billion) - China Securities Star Market 50 ETF (0.682 billion) - Guotai Junan CSI All Index Securities Company ETF (0.47 billion) [11] - The highest margin sell amounts were for: - Huatai-PB CSI 300 ETF (63.87 million) - China Securities Star 50 ETF (34.55 million) - Southern CSI 500 ETF (23.85 million) [12] Institutional Insights - Century Securities suggests focusing on the transformation progress of leading companies in the medical device sector, which has gained market share post centralized procurement [13] - Guojin Securities emphasizes investment strategies in the medical device sector should focus on overseas expansion and innovation, as these areas provide additional growth opportunities and support profit margins during price declines in traditional businesses [14]